Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
La Revue De Medecine Interne
|
September 21, 2013
[Smoldering multiple myeloma]
G Fouquet, S Guidez, C Herbaux, et al.
Medecine Et Maladies Infectieuses
|
August 22, 2017
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
C Robin, R Héquette-Ruz, B Guery, et al.
Current Research in Translational Medicine
|
September 8, 2018
Acute polyradiculopathy secondary to idelalisib in Relapsed Classical Hodgkin's lymphoma
S Barbieux, E M Boyle, C Baillet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 21, 2018
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid
D Beauvais, J-F Goossens, E Boyle, et al.
La Revue De Medecine Interne
|
August 11, 2015
[Pomalidomide for multiple myeloma]
G Fouquet, M Macro, O Decaux, et al.
Bone Marrow Transplantation
|
November 29, 2016
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma
D Ghez, C Fortpied, N Mounier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group
E Tchernonog, P Faurie, P Coppo, et al.
British Journal of Haematology
|
May 16, 2023
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA
A Marouf, N Molinari, D Sibon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 30, 2020
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G Manson, P Brice, C Herbaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2021
Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G Manson, P Brice, C Herbaux, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
La Revue De Medecine Interne
|
September 21, 2013
[Smoldering multiple myeloma]
G Fouquet, S Guidez, C Herbaux, et al.
Medecine Et Maladies Infectieuses
|
August 22, 2017
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
C Robin, R Héquette-Ruz, B Guery, et al.
Current Research in Translational Medicine
|
September 8, 2018
Acute polyradiculopathy secondary to idelalisib in Relapsed Classical Hodgkin's lymphoma
S Barbieux, E M Boyle, C Baillet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 21, 2018
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid
D Beauvais, J-F Goossens, E Boyle, et al.
La Revue De Medecine Interne
|
August 11, 2015
[Pomalidomide for multiple myeloma]
G Fouquet, M Macro, O Decaux, et al.
Bone Marrow Transplantation
|
November 29, 2016
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma
D Ghez, C Fortpied, N Mounier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group
E Tchernonog, P Faurie, P Coppo, et al.
British Journal of Haematology
|
May 16, 2023
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA
A Marouf, N Molinari, D Sibon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 30, 2020
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G Manson, P Brice, C Herbaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2021
Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G Manson, P Brice, C Herbaux, et al.
Page
of 2